These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2413894)

  • 1. Plasminogen activation and regulation of pericellular proteolysis.
    Saksela O
    Biochim Biophys Acta; 1985 Nov; 823(1):35-65. PubMed ID: 2413894
    [No Abstract]   [Full Text] [Related]  

  • 2. Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators.
    Golder JP; Stephens RW
    Eur J Biochem; 1983 Nov; 136(3):517-22. PubMed ID: 6416839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minactivin expression in human monocyte and macrophage populations.
    Stephens RW; Golder JP; Fayle DR; Hume DA; Hapel AJ; Allan W; Fordham CJ; Doe WF
    Blood; 1985 Aug; 66(2):333-7. PubMed ID: 3926024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma fibrinolysis inhibitors].
    Nowak S; Nowak A
    Pol Arch Med Wewn; 1985 Feb; 73(2):113-21. PubMed ID: 2410893
    [No Abstract]   [Full Text] [Related]  

  • 5. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
    Wijngaards G
    Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Mechanism of fibrinolysis].
    Matsuda T
    Rinsho Byori; 1985 Sep; 33(9):982-8. PubMed ID: 2416968
    [No Abstract]   [Full Text] [Related]  

  • 8. Cultured granulosa cells produce two plasminogen activators and an antiactivator, each regulated differently by gonadotropins.
    Ny T; Bjersing L; Hsueh AJ; Loskutoff DJ
    Endocrinology; 1985 Apr; 116(4):1666-8. PubMed ID: 3918858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activation in healing human wounds.
    Schäfer BM; Maier K; Eickhoff U; Todd RF; Kramer MD
    Am J Pathol; 1994 Jun; 144(6):1269-80. PubMed ID: 8203466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasminogen activators and their physiological role].
    Andreenko GV
    Ukr Biokhim Zh (1978); 1983; 55(3):329-43. PubMed ID: 6346623
    [No Abstract]   [Full Text] [Related]  

  • 11. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
    Clemmensen I; Thorsen S; Müllertz S
    Haemostasis; 1976; 5(4):218-30. PubMed ID: 826461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of plasminogen activators and inhibitors with plasminogen and fibrin.
    Lijnen HR; Collen D
    Semin Thromb Hemost; 1982 Jan; 8(1):2-10. PubMed ID: 6460318
    [No Abstract]   [Full Text] [Related]  

  • 13. Microplate immunocapture assay for plasminogen activators and their specific inhibitors.
    Stephens R; Leung KC; Pöllänen J; Salonen EM; Vaheri A
    J Immunol Methods; 1987 Dec; 105(2):245-51. PubMed ID: 3121752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasminogen activators in tumor tissue].
    Tomasiuk R; Mirowski M; Wierzbicki R
    Pol Arch Med Wewn; 1989 Jun; 81(6):355-63. PubMed ID: 2517455
    [No Abstract]   [Full Text] [Related]  

  • 15. [Enzymatic determination of plasminogen activators].
    Fischer BE
    Z Med Lab Diagn; 1988; 29(6):327-32. PubMed ID: 2973186
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of the plasminogen activator urokinase by alpha-tocopherol.
    Ogston D
    Acta Haematol; 1982; 67(2):114-8. PubMed ID: 6801892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The plasmin-antiplasmin system: structural and functional aspects.
    Schaller J; Gerber SS
    Cell Mol Life Sci; 2011 Mar; 68(5):785-801. PubMed ID: 21136135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator: chemical and physiological aspects.
    Bachmann F; Kruithof IE
    Semin Thromb Hemost; 1984 Jan; 10(1):6-17. PubMed ID: 6422555
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recent progress in fibrinolytic mechanism].
    Yasukouchi T
    Rinsho Byori; 1986 Mar; 34(3):235-46. PubMed ID: 3086600
    [No Abstract]   [Full Text] [Related]  

  • 20. Properties of a partially purified preparation of a circulating plasminogen activator.
    Ogston D; Bennett B; Mackie M
    Thromb Res; 1976 Mar; 8(3):275-84. PubMed ID: 131386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.